ȸ¿ø°¡ÀÔ | ¿¬¶ôó | »çÀÌÆ®¸Ê | English

      È¸»ç¼Ò°³ | ¸®Æ÷Æ® | Ä¿½ºÅÒ ¸®¼­Ä¡ | °í°´Áö¿ø


·Î±×ÀÎ

Ä«Å×°í¸®

À¯/¹«¼±Åë½Å

Àü±â/ÀüÀÚ

µðÁöÅбâ±â/¹Ìµð¾î/¹æ¼Û

Information Technology

¿¡³ÊÁö

»ý¸í°øÇÐ

È­ÇÐ/½Å¼ÒÀç

ÀÚµ¿Â÷

ȯ°æ

ÀϹݼҺñÀç

¸¶ÄÉÆÃ/±¤°í

±ÝÀ¶

°Ç¼³

±³Åë/¿î¼Û

¼ÒºñÀÚÁ¶»ç

¹æÀ§/Ç×°ø/¿ìÁÖ

½ÄÀ½·á

Áß°ø¾÷

±³À°

±â°è

¹«¿ª

½ºÆ÷Ã÷/·¹Àú

ÇØ¿î/Á¶¼±

ÆмÇ

Á¤ºÎ/Á¤Ã¥

°ø¿¹/±Í±Ý¼Ó

ÄÄÆÛ´Ï ÇÁ·ÎÆÄÀÏ

±âŸ»ê¾÷

 
ÇöÀçÀ§Ä¡ : HOME > ¸®Æ÷Æ® > »ý¸í°øÇÐ > Áø´Ü
2015-2019 World Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies
¹ßÇà»ç VPG Market Research

¹ßÇàÀÏ 2015-06
ºÐ·® 570 pages
¼­ºñ½ºÇüÅ Report
ÆǸŰ¡°Ý

ÀμâÇϱâ

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.

This new seven-country study from VPGMarketResearch contains 570 pages, 42 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.


ȸ»ç¼Ò°³ | °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ | ÀÌ¿ë¾à°ü | ¹è¼Û/°áÁ¦¾È³» | ÀÌ¿ë¾È³»

¼­¿ï½Ã °­³²±¸ ³íÇöµ¿ 210-1 »ï¿øºôµù | ȸ»ç¸í : (ÁÖ)¿¤¾Ø¿¡Ä¡
´ëÇ¥ÀüÈ­ : 02-554-0001 / Æѽº : 02-3444-5501 / À̸ÞÀÏ : sales@landh.co.kr
Copyright ¨Ï 2008 LNH, Inc. All rights reserved.